Getinge Postpones Financial Review Following FDA Feedback
This article was originally published in The Gray Sheet
Executive Summary
The Swedish conglomerate pushed off a planned Capital Markets Day based on a communication from FDA about Getinge’s ongoing efforts to remediate its quality management systems. The firm did not disclose the details of the agency’s feedback, but explained that it added too much uncertainty for executives to discuss a financial outlook.